EP-1633: Analysis of Dose-Volume Histogram parameters on prediction esophageal toxicity in radiotherapy for lung tumors  by Valero Fita, J. et al.
S894                                                                                                                                         3rd ESTRO Forum 2015 
 
method; 2) Target-divided optimizing (TDO) method in which 
the optimization objective was set to 2-4 Gy higher for the 
planning target volume (PTV) within lung; 3) Base-dose-
function (BDF) method: with optimization objectives being 
unmodified, the treatment plan copied from the original plan 
with half of total fractions was re-optimized based on the 
original plan with half of total fractions, and then the 
number of fractions of treatment plan was restored from a 
half to the total one. CO, TDO and BDF methods were then 
compared in PTV homogeneity index (HI), conformity index 
(CI), organs at risk (OARs) sparing and monitor units (MUs). 
Additionally, three verification tools, Delta4, Portal 
Dosimetry and IMSure were employed to measure the dose 
delivery accuracy. 
Results: BDF method provided superior HI over TDO and CO 
methods by about 38% and 54% respectively, and provided 
superior CI over TDO and CO methods by about 3% and 7% 
respectively. Considering the OARs sparing, BDF method 
reduced the dose delivered to the lung, spinal cord, 
esophagus and heart by about 0.2-3.8Gy. However, the BDF 
plans needed about 9-15% more monitor units (MUs) than the 
other two methods. All the verification results had good and 
comparable γ pass rates among the 3 methods.  
 
 
 
Conclusions: The proposed BDF method can achieve 
excellent homogeneous dose distribution, and it can also 
improve the target conformity as well as the OARs sparing, in 
the IMRT for Stage III lung cancer. 
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Purpose/Objective: A Generic Template with no specific 
adjustments for tumour type is used at our hospital for linear 
accelerator-based radiosurgery treatment planning. It 
involves further manual adjustments of the micro-multileaf 
collimator (mMLC) leaves in all the generic arcs for improving 
the treatment plan quality which is a cumbersome task. The 
purpose of this work is to present specific templates for right 
and left acoustic neurinomas and compare their performance 
with the Generic Template in terms of plan quality, and to 
determine the minimum number of arcs where the mMLC 
shape must be adjusted for the treatment plan to comply 
with the local acceptability criteria. 
Materials and Methods: The treatment plans of 12 cases of 
already treated right acoustic neurinomas were analysed. 
From this retrospective study, a Specific Template for right 
acoustic neurinoma was created and the Specific Template 
for left acoustic neurinoma was defined as precisely the 
mirror of the right template. In total, 19 cases involving 
acoustic neurinomas have been re-planed with the Specific 
Template (right or left) and their plan quality assessed. 
Treatment planning was conducted using the iPlan RT Dose 
planning system, version 4.5 from BrainLAB. The target 
volumes ranged from 0.265-7.523 cc (mean: 2.085 ± 1,772 cc) 
and the prescribed dose was 12-14 Gy (mean: 12.15 ± 0.50 
Gy). Treatment plans were generated using 6 dynamic 
conformal arcs and their quality evaluation was assessed 
through the calculation of dose-volume indices and dose 
distribution analysis. 
Results: The Specific Template performed better than the 
Generic Template in terms of conformity (COIN = 0.558 ± 
0.034 for the Specific Template and COIN = 0.547 ± 0.034 for 
the Generic Template) and critical organ sparing (COIN’= 
0.554 ± 0.031 for the Specific Template and COIN’ = 0.538 ± 
0.031 for the Generic Template). The coverage and the 
homogeneity of the dose distribution were similar for both: 
TC = 0.981 ± 0.007, MDPD = 1.065 ± 0.013 for the Specific 
Template and TC = 0.984 ± 0,007, MDPD = 1.067 ± 0.013 for 
the Generic Template. 
Conclusions: Applying the proposed Specific Template for 
acoustic neurinoma, the compliance to local acceptance 
quality criteria was achieved with manual correction of the 
mMLC leaves for just two of the six dynamic arcs used for 
treatment. This represented a considerable reduction – to 
around 1/3 - of the treatment planning time, accomplishing 
the purpose of the present work which was speeding up the 
treatment planning phase in radiosurgery without 
jeopardizing the plan quality. 
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Purpose/Objective: Esophageal toxicity is a common acute 
side-effect of external radiotherapy for chest tumors. There 
is no clear relation with different etiologies as esophageal 
doses, length of irradiated organ, volumes, etc. Dose-volume 
histogram (DVH) shows several parameters that can help us 
to understand this toxicity 
Our objective was to analyze esophageal toxicity at the end 
of radiotherapy treatment and relate it with the DVH 
parameters mean dose (Dmean) and maximum dose (Dmax)  
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Materials and Methods: We analyze 51 patients (48, male; 3 
female), aged from 42 to 84 years; diagnosed of lung tumors, 
and treated with external beam radiotherapy. 
Radiotherapy treatment was delivered with linear accelerator 
CLINAC 2100 (Varian). 3D planning was performed with 
Pinnacle System software (Phillips). For the analysis we 
select the Dose-Volume Histogram (DVH) parameters mean 
dose (Dmean) and maximum dose (Dmax). 
Acute esophageal toxicity was evaluated at end of treatment 
with the RTOG acute side effects scale 
Results: Median total dose was 60Gy (45-63 Gy). Mediastinal 
median dose was 50Gy (45-60Gy) 
Twenty three patients (45%) did not have esophageal toxicity 
at end of radiotherapy. Grade 1 was achieved in 23 patients 
(45%), and grade 2 in 5 (10%) (Fig. 1) 
Esophageal Dmean:  
Dmean range: 23.6-33.2Gy. The median of Dmean in patients 
without toxicity was 31.6 Gy; in patients with toxicity (grade 
1 or 2): 33.2 Gy. This difference was not statistically 
significant (p=0.77) (Fig. 2) 
Esophageal Dmax:  
Dmax range: 51-63Gy. The median in patients without 
toxicity was 58Gy; and median in patients with toxicity 
(grade 2 or 3): 59.2Gy. These differences were not 
statistically significant: p=0.289  
 
 
Fig. 1. Toxicity at end of radiotherapy 
 
 
Fig. 2.- Distribution of toxicity and Mean Dose (Dmean) 
 
Conclusions: Esophageal toxicity was mild: 45% of patients 
did not develop any grade of dysphagia.  
The median Dmean in the esophagus in patients who 
developed some degree of toxicity was slightly higher than in 
patients with no toxicity; however, these differences were 
not statistically significant, so Dmean can´t help us to 
predict esophageal toxicity. 
The median Dmax achieved in the esophagus was slightly 
higher in patients who experienced toxicity at the end of 
treatment, but the differences with patients without toxicity 
were not statistically significant, so we can conclude that the 
Dmax parameter is not useful for esophageal predict toxicity. 
In our study the DVH parameters Dmean and Dmax have not 
been useful in predicting toxicity in patients with external 
beam radiation. We can´t stablish these parameters as 
predictors of esophageal toxicity. 
A higher number of patients or the analysis of other DVH 
parameters could reach a level of statistical significance that 
allowed relate esophageal toxicity. 
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Purpose/Objective: Many studies have compared field-in-
field (FIF) radiotherapy with conventional radiotherapy using 
the wedge technique in breast cancer, but a study comparing 
the effectiveness of these modalities in cervical lymphoma 
has not yet been reported. The current study was conducted 
to evaluate the clinical benefit of the FIF technique 
compared with conventional radiotherapy with physical 
wedges for the treatment of unilateral cervical malignant 
lymphoma. 
Materials and Methods: Two treatment plans against 
unilateral cervical malignant lymphoma were generated to 32 
patients: for the FIF technique and for the wedge technique. 
The clinical target volume included the ipsilateral neck node 
levels I–VI, the parotid area, and the volume of pre-
chemotherapy involved lymph nodes plus a 5-mm margin. A 
total dose of 30 Gy in 15 daily fractions of 2 Gy was planned. 
To compare the two treatment plans, dose-volume 
histograms of the planning target volume (PTV), the thyroid, 
submandibular gland, carotid artery, mucosa, spinal cord, 
and surrounding normal tissue, and monitor unit (MU) were 
analyzed. Analyses were performed using the Wilcoxon signed 
rank test to determine if there was a significant difference in 
any of the parameters examined. 
Results: The FIF technique showed significant reduction in 
the maximum doses and the volume receiving >107% of the 
